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Abstract
Background: The expression of the clonally variant virulence factor PfEMP1 mediates the sequestration of Plasmodium
falciparum infected erythrocytes in the host vasculature and contributes to chronic infection. Non-cytoadherent parasites
with a chromosome 9 deletion lack clag9, a gene linked to cytoadhesion in previous studies. Here we present new clag9
data that challenge this view and show that surface the non-cytoadherence phenotype is linked to the expression of a non-
functional PfEMP1.
Methodology/Principal Findings: Loss of adhesion in P. falciparum D10, a parasite line with a large chromosome 9 deletion,
was investigated. Surface iodination analysis of non-cytoadherent D10 parasites and COS-7 surface expression of the CD36-
binding PfEMP1 CIDR1a domain were performed and showed that these parasites express an unusual trypsin-resistant, non-
functional PfEMP1 at the erythrocyte surface. However, the CIDR1a domain of this var gene expressed in COS-7 cells
showed strong binding to CD36. Atomic Force Microscopy showed a slightly modified D10 knob morphology compared to
adherent parasites. Trafficking of PfEMP1 and KAHRP remained functional in D10. We link the non-cytoadherence
phenotype to a chromosome 9 breakage and healing event resulting in the loss of 25 subtelomeric genes including clag9.I n
contrast to previous studies, knockout of the clag9 gene from 3D7 did not interfere with parasite adhesion to CD36.
Conclusions/Significance: Our data show the surface expression of non-functional PfEMP1 in D10 strongly indicating that
genes other than clag9 deleted from chromosome 9 are involved in this virulence process possibly via post-translational
modifications.
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Introduction
An important factor contributing to the virulence of Plasmodium
falciparum is the ability of parasitized red blood cells (PRBC) to
adhere to receptors such as CD36 or ICAM-1 expressed on the
surface of endothelial cells, or chondroitin sulphate A (CSA)
expressed on placental syncytiotrophoblasts (see [1] for a review).
PRBC sequestration can lead to complete blockage of the
microvasculature resulting in severe disease including cerebral
malaria that may be fatal [2].
Parasite survival within the newly invaded erythrocyte depends
on the synthesis and export of several components, which will be
used to build the trafficking pathway and channels necessary for
the import and export of essential constituents (see [3]). The
variant antigen P. falciparum erythrocyte membrane protein 1
(PfEMP1) is the predominant ligand responsible for adhesion to
host endothelial receptors and is essential for parasite survival and
establishing chronic infection [2]. Approximately 60 var genes of
the parasite’s haploid genome encode for PfEMP1 and their
expression occurs in a mutually exclusive manner. The var genes
share a two exon structure with exon 1 coding for the extracellular
highly variable adhesive region and a conserved cytoplasmic exon
2 that codes for a transmembrane region (TM) and interacts with
the red blood cell cytoskeleton [4]. Exon 1 is composed of variable
numbers of Duffy binding-like domains (DBL) and Cysteine-Rich
Interdomain Regions (CIDR) that specifically bind to the different
receptors in adhesion assays when expressed in heterologous
expression systems [5–7].
During in vitro culture, var genes are transcribed and translated
in ring stages and, despite the absence of an N-terminal signal
sequence [8], PfEMP1 is exported through the endoplasmic
reticulum pathway, and beyond the parasite’s confines to the
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structural component Knob-Associated Histidine-Rich Protein
(KAHRP) [9]. In general, a single var gene is expressed in a
parasite, but expression can switch to another member in the
absence of an immune pressure, leading to antigenic and
phenotypic variation at the PRBC surface [10]. This is believed
to drive escape from the host’s immune response and is implicated
in pathogenesis.
A recent large-scale knockout study highlighted the complexity
of the interaction between parasite proteins secreted into the RBC
cytoplasm and cytoadhesion [11]. In this work and other studies
several proteins were identified that contribute either in loading
PfEMP1 into Maurer’s clefts [11] or transfer from the clefts to the
erythrocyte surface [11–13]. Although this fascinating mechanism
is being intensely studied, many cellular processes involved in
trafficking of parasite proteins into the host cell remain elusive
[3,14]. In this work we identified P. falciparum laboratory lines that
have irreversibly lost their adhesive properties but express non-
functional and trypsin-resistant PfEMP1 molecules on the surface
of PRBC. Furthermore, to determine if loss of cytoadherence may
have resulted from the absence of the cytoadherence-linked
asexual gene (clag9) due to the truncation of chromosome 9 in D10,
we performed targeted disruption of clag9 and show, that in
contrast to previous studies [15,16], this gene is not essential for
the cytoadhesion of PfEMP1.
Methods
Parasites and cell cultures
Plasmodium falciparum D10, a cloned line derived from FC27
[17], FCR3 [18], Malayan Camp (MC) [19] and 3D7 [20] were
cultured as described [21]. All parasite strains were systematically
selected for the presence of knobs by gelatine flotation (Plasmion,
Fresenius Kabi, France) [22]. Parasite cultures were synchronized
by sorbitol lysis [23] and verified for the absence of mycoplasma
that could interfere with cytoadhesion [24]. Amelanotic C32
melanoma cells [25] and COS-7 cells [6] were grown in RPMI
1640 without glutamine (Invitrogen), supplemented with 10%
foetal bovine serum (heat-inactivated), 0.4 mM L-glutamine,
20 mM HEPES and penicillin/streptomycin.
Nucleic acids extraction and analysis
Total RNA from 3D7, D10 and FCR3 was isolated by the
addition of TRIzol (Invitrogen) to the harvested ring-, trophozoite-
and schizont-PRBC [26], processed as described [27], transferred
onto Hybond N+ (Amersham) and hybridized with
32P-labelled
DBL1a or ATS (Acidic Terminal Segment) probes.
Cultured parasites were permeabilized with 0.15% saponin [28]
before extraction of genomic DNA (GenElute Mammalian
Genomic DNA miniprep kit, Sigma). The full PfEMP1 gene
sequence was obtained by PCR amplification and determined by
gene walking (Supplementary Table 1), and is available from
Genbank (accession number JF342594).
For Southern blotting genomic DNA was digested with EcoRI
and SpeI (BioLabs), and processed as described [29]. Northern and
Southern blots were washed with sodium saline citrate (SSC),
sodium dodecyl sulfate (SDS) at 60uC and exposed with BioMax
MS films and Transcreen HE (Kodak).
clag9 Knockout
P. falciparum 3D7 genomic DNA was used to PCR amplify clag9
exons 1 (bp 1 to 761) and 8 (bp 3652 to 4418) (Supplementary
Table 1), the fragments were digested with SacII/SpeI and
EcoRI/NcoI, and cloned into the vector pCC1 [30]. P. falciparum
was transfected with this construct leading to the disruption of
clag9 by allelic exchange and insertion of the hDHFR selectable
marker.
Antibodies
Pooled human immune sera [31], anti-Pf332 mAb51-22 and
rabbit purified IgG [32], anti-KAHRP mAb89 [33], anti-CD36
mAbFA6-152 [34], and mAb7H8/50 [35] have been described.
Anti-Gluthathione S-transferase (GST) mAb clone GST-2 (Sig-
ma), anti-hemagglutinin A mAb16B12 (Abcam), fluorochrome-
conjugated secondary antibodies (Molecular Probes), and guinea
pig anti-ATS serum (Charles Rivers Laboratories, France) were
also used.
Indirect Immunofluorescence Assay (IFA)
Immunofluorescence assays were done as previously described
[32]. Surface immunofluoresence assays of D10 and FCR3
CD36
were performed on trypsin-treated PRBC using pooled human
immune sera (1:5) followed by anti-human Alexa Fluor 488
(1:100). Nuclei were stained with 0.2 mg/ml 49,6-diamidino-2-
phenylindole (DAPI; Molecular Probes) and 10 mg/ml propidium
iodide (Sigma) to confirm cell viability. Parasites were visualized by
confocal fluorescence microscopy (Nikon Eclipse TE2000-E), the
images were captured with a Nikon D-Eclipse C1 camera and
Nikon EZ-C1 software version 3.80.
Iodination and Immunoprecipitation
Plasmion-enriched PRBC were labelled with
125I before
incubation with different concentrations of trypsin (0, 10, or
100 mg/ml) or chymotrypsin (100 mg/ml) as described [36]. The
Triton-X100 insoluble-SDS soluble (TX100ins-SDSsol) fractions
were immunoprecipitated with a pool of human immune sera
[31].
Western blot
Western blots were performed as described [32]. TX100ins-
SDSsol extracts from trypsin-treated mature parasites were reacted
with anti-ATS serum (1:400) followed by alkaline phosphatase-
conjugated anti-guinea pig secondary antibodies (1:2500) and
developed with NBT/BCIP (Promega). The clag9 knockout clones
KOE5 and KOF4 were similarly analysed using rabbit anti-
CLAG9 antibodies (1:1000) [37] and revealed with SuperSignal
West Pico Chemiluminescent Substrate (Pierce, Thermo Scientif-
ic).
CIDR1a binding analysis
The M2 CIDR1a domain (minimal CD36 binding site) [38]
from the following var genes: D10
var1 (this work), FCR3
var1CSA [36],
and MC
varCD36 [38] were cloned into the pDisplay vector
(Invitrogen) (Supplementary Table 1) and expressed on the surface
of COS-7 cells [39]. CD36 binding assays were performed as
described [36,39] using magnetic protein A-conjugated Dynal
beads (Invitrogen) and mAbFA6-152. The efficiency of COS-7
transfection was verified by detection of the pDisplay HA tag by
IFA with mAb16B12 followed by anti-mouse Alexa Fluor 488.
Cytoadherence assay
Assays were performed as described [36] with 10 ml of purified
receptors immobilized on plastic Petri dishes: 10 mg/ml CD36 and
ICAM-1 (R&D systems), 5 mg/ml gC1qR [40], 1 mg/ml CSA and
CSC (Sigma). Control spots were coated with 1% BSA (fraction V,
Sigma). FCR3 panned on CD36 (FCR3
CD36) was used as positive
control.
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Plasmion-selected trophozoites and schizonts were fixed in 4%
paraformaldehyde and 0.1% glutaraldehyde for 30 min on ice and
washed twice with PBS. PRBC were immobilized on glass bottom
WillCo dishes (WillCo Wells) activated using a low-pressure
plasma 02 (Femto, Diener Electronic) [41,42]. The dishes were
then covered with poly-L-lysine (Sigma) for 1 hour and rinsed with
water. Experiments were conducted at room temperature on a
stand alone AFM (Bioscope 2, Veeco Instruments) equipped with a
Nonoscope V controller, mounted on an optical inverted
microscope (Axiovert 200 M, Zeiss). Bright-field video images
were acquired with a CoolSnapES camera (Roper Scientific) driven
under MetaMorph software (Molecular Devices). AFM images
were acquired in Tapping Mode
TM using Veeco’s silicon RTESP
Tip (radius of curvature ,10 nm), plane-fitted (1
st order), and
processed under Vision software to get 3D representation. Height
profiles of typical knobs were acquired with Veeco’s integrated
software and plotted using R 2.6.1. For each parasite strain three
images showing the greatest dispersion in knobs sizes were
selected.
Statistical Analysis
Data were analysed with MinitabH 15 using a 1-way analysis of
variance (ANOVA), including Tukey’s test for multiple compar-
isons.
Results
P. falciparum D10 binding assays
Previous studies have shown that P. falciparum bulk-cultured
parasites can be enriched for their binding to specific endothelial
cell receptors [43]. C32 melanoma cells mainly express the CD36
receptor on their surface, and in lesser amounts the receptors
ICAM-1 and CSA [44,45]. To determine the adhesive properties
of P. falciparum D10 PRBC, we performed binding assays on C32
cells [25]. Asynchronous cultures of P. falciparum D10 and
FCR3
CD36 were incubated with C32 cells, carefully washed to
remove unbound PRBC, and the number of adherent PRBC
determined. We observed that D10 PRBC did not bind to the
melanoma cells, whereas FCR3
CD36-infected erythrocytes were
seen to adhere (Fig. 1A and B). Furthermore, no D10 adhesion
Figure 1. Binding assay on C32 melanoma cells. A. P. falciparum D10 mature stages are unable to bind to expressed receptors of C32
melanoma cells (CD36&ICAM-1&CSA) compared to the positive control FCR3
CD36. B. The graph illustrates the number of bound PRBC per 100 C32
cells for FCR3
CD36 (black) and D10 (white). Results are the means 6 standard deviation from five experiments. C. Microscopic images of Giemsa
stained FCR3
CD36 and D10 on purified receptors. D. Quantification of binding assays for FCR3
CD36 (black) and D10 (white) on purified receptors
spotted on plastic Petri dishes. Results are the means 6 standard deviation from five experiments.
doi:10.1371/journal.pone.0029039.g001
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endothelial cells (HUVEC), a line to which some non-cytoadher-
ent parasites are able to bind [46].
As several adhesins are implicated in the cytoadherence of
PRBC, we further tested the binding of PRBC on purified
CD36, ICAM-1, and some receptors rarely expressed in in vitro
culture such as CSA and gC1qR. We did not observe any
detectable binding of D10 to the tested receptors, which is in
clear contrast to FCR3
CD36 control adherence experiments
(Fig. 1C and D). Repeated panning assays (3 times) on C32 cells
and CD36 receptor did not yield any increase in adherence
supporting the idea that D10 has irreversibly lost the adhesion
phenotype.
Characterization of the P. falciparum D10 variant PfEMP1
RT-PCR analysis using primers to amplify the conserved
DBL1a domain indicated that a single type of var gene is
transcribed by ring stage D10 parasites [47]. Northern blot
analysis using a probe corresponding to the DBL1a domain of this
var gene showed a unique major 8 kb transcript in ring stages
(Fig. 2A, lane 1). This transcript was not observed in D10
trophozoites and schizonts (Fig. 2A, lane 2) or in any FCR3
CD36
blood stages (data not shown). Successive hybridization with a
conserved ATS probe confirmed that a single major transcript is
present in ring stages of D10 (Fig. 2A, lanes 3, 4).
Next, we verified whether the var transcript was translated into
the protein PfEMP1 and expressed on the surface of the PRBC.
Figure 2. Analysis of P. falciparum D10. A. Northern blot. Total RNA (10 mg) from P. falciparum D10 intra-erythrocytic stages hybridized with the
D10 DBL1adomain of PfEMP1 probe (lanes 1–2), the expected 8 kb transcript was detected. The same membrane was hybridized with the ATS probe
to control for loading (lanes 3–4). R: Ring stages (6–12 h after invasion), S: Schizonts (34–36 h after invasion). Size markers are in kb. B–D. Effect of
trypsin on PfEMP1 of FCR3
CD36 and D10 strains. B. Surface iodination. SDS-PAGE analysis of
125I-labelled FCR3
CD36 (lanes 1–3) and D10 (lanes 4–6). C.
Immunoprecipitation of FCR3
CD36 (lanes 1–3) and D10 (lanes 4–6) TX100ins-SDSsol trypsin-treated extracts with a pool of human immune sera.
Arrowheads indicate the PfEMP1 antigen. Molecular weight markers are in kDa. D. Western blot. Mature FCR3
CD36 and D10 parasites were treated
with 0 mg/ml (lanes 1 and 3), 10 mg/ml (lanes 2 and 4), or 100 mg/ml trypsin (lanes 3 and 6). TX100ins-SDSsol extracts were probed with goat anti-ATS
and alkaline phosphatase-conjugated anti-goat and revealed with NBT/BCIP. The ATS antigen is shown by an arrow and an arrowhead indicates full-
length PfEMP1. The same membrane was reacted with Hsp70 antibodies to control for loading. E. Surface immunofluorescence of FCR3
CD36 and D10.
Plasmion-selected parasites were treated with trypsin prior to incubation with pooled human immune sera (PIAG) followed by goat anti-human IgG
Alexa Fluor 488. Scale bars: 5 mm.
doi:10.1371/journal.pone.0029039.g002
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with a pool of human immune sera showed that both FCR3
CD36
and D10 displayed a protein of apparent high molecular weight of
approximately 300 kDa present in the TX100ins-SDSsol fraction.
Whereas the positive control FCR3
CD36 was readily digested by
10 mg/ml of trypsin (Fig. 2B and C, lanes 1–3), the PfEMP1
expressed by D10 was quite insensitive to digestion with even
100 mg/ml of trypsin (Fig. 2B and C, lanes 4–6) or 100 mg/ml of
chymotrypsin (data not shown). A ,75 kDa fragment correspond-
ing to the intracellular domain of PfEMP1 was detected by
Western blotting exclusively in the FCR3
CD36 trypsin-treated
extracts reacted with anti-ATS antibodies (Fig. 2D lane 1–3). In
contrast, these antibodies reacted with the full-length PfEMP1 of
D10 treated extracts (Fig. 2D lane 4–6).
PfEMP1 localization was also confirmed by surface IFA of live
PRBC following trypsin treatment. As predicted surface labelling
was sensitive to trypsin in FCR3 and resistant in D10 parasites
(Fig. 2E). Furthermore, cell integrity was verified by propidium
iodide stanning (data not shown). These findings indicated that a
trypsin-resistant PfEMP1 is expressed on the surface of D10 that
has lost its adhesive properties.
Protein trafficking by P. falciparum D10
To further investigate the non-binding phenotype we analyzed
by immunofluorescence whether intracellular protein trafficking
was affected in D10 parasites. Several P. falciparum polypeptides are
exported through the red blood cell cytoplasm in association with
the Maurer’s clefts, and these may be essential for the correct
assembly of the cytoadherence complex at the PRBC surface [48].
PRBC double-labelled with the Maurer’s clefts marker Pf332 and
PfEMP1 antibodies (Fig. 3A), showed that PfEMP1 was associated
with the Maurer’s clefts in transit through the RBC cytoplasm.
Comparable results were obtained with the FCR3
CD36 PRBC
(Fig. 3A), however, the D10 Maurer’s clefts labelling detected with
anti-Pf332 appeared more diffuse than in FCR3
CD36 suggesting a
different morphology. A similar altered Maurer’s clefts architec-
ture was observed in REX1 mutant parasites [49], one of the 25
genes lost in the chromosome 9 deletion of D10.
Furthermore, mAb89 reacted with knobs at the RBC
membrane of D10-infected erythrocytes indicating that KAHRP,
which interacts with the PfEMP1 ATS region, is correctly
addressed to the RBC membrane (Fig. 3B). These data suggest
that trafficking and export of the studied marker proteins and
PfEMP1 are apparently not affected in D10 parasites.
Because PfEMP1 is anchored to the cytoskeleton of the infected
erythrocyte through interactions with the knob component
KAHRP, we verified if the knobs from D10 had a structure
similar to parasites expressing functional PfEMP1 on their surface.
The visualisation by AFM of the PRBC revealed only subtle
changes in the knob morphology between D10 and FCR3
CD36
(Fig. 4A). No difference was observed in the amount of knobs and
their distribution on the erythrocyte surface for these strains. The
Figure 3. Localization of parasite exported proteins. A. Double-labelling of synchronous air-dried D10 (top row) and FCR3
CD36 (bottom row)
with guinea pig anti-PfEMP1 antibodies (1:500) and purified rabbit anti-Pf332 IgG (1:200) revealed with a mixture of goat anti-guinea pig Alexa Fluor
488 (1:500) and Alexa Fluor 594-conjugated anti-rabbit IgG (1:1000). B. Labelling of PfEMP1 (1:500, green) and knobs on the PRBC surface with
monoclonal anti-KAHRP (mAb89, 1:800, red), followed by anti-guinea pig Alexa Fluor 488 and anti-mouse Alexa Fluor 594. Scale bars: 5 mm.
doi:10.1371/journal.pone.0029039.g003
Adhesion Is Not Linked to clag9 Deletion
PLoS ONE | www.plosone.org 5 December 2011 | Volume 6 | Issue 12 | e29039diameter and height of D10 knobs were slightly smaller than that
from FCR3
CD36 (Fig. 4A and B). These results imply that although
the knob morphology is marginally affected by the chromosome 9
deletion it is not causing the loss of cytoadherence of D10
parasites.
The CIDR1a domain of the PfEMP1 expressed in D10
binds to CD36
We cloned and sequenced the entire var gene transcribed in D10
(called D10
var1) and determined that the open reading frame of this
transcript is composed of NTS-DBL1a-CIDR1a-DBL2d-
CIDR2b-TM-ATS domains (Fig. 5A). The different domains of
PfEMP1 can be classed according to their binding regions allowing
the prediction of the corresponding adhesion receptors [5,39]. The
M2 minimal domain from PfEMP1 CIDR1a is necessary and
sufficient for binding to the CD36 receptor [38]. Thus, to better
characterize D10
var1, the HA tagged M2 domain was expressed on
the surface of COS-7 cells (Fig. 5A). Cells were incubated with
recombinant CD36 and M2-CD36 surface complexes we detected
using anti-CD36 mAb-coated Dynal beads. COS-7 cells surface-
expressing the M2 domain from D10
var1 and the positive control
MC
varCD36 are shown in Fig. 5B. No significant differences
(P=0.961) in binding were observed. In contrast, COS-7 cells
expressing M2 domain from the negative control FCR3
var1CSA,
showed significantly less coated beads on the surface (P,0.001)
(Fig. 5B and C). Transfected COS-7 cells expressing M2 domains
were visualized after the binding assay by IFA staining of the HA-
domain fused to M2 (green fluorescence). Our results demonstrate
that the M2 domain of D10
var1 is functional when expressed
outside the D10 infected erythrocyte context and indicate that
D10 PRBC have lost their capacity for functional expression of
parasite-mediated adhesion, maybe due either to a conformational
defect, improper insertion into the RBC membrane, or missing
post-translational modifications of PfEMP1.
Figure 4. AFM analysis of erythrocytes infected by P. falciparum FCR3
CD36 and D10. A. Representative amplitude images of infected red
blood cells. Insets show Giemsa staining of the analysed PRBC. B. Height images were used to measure knob homogeneity, number, diameter and
height on infected erythrocytes. Knob homogeneity and number were analyzed using mean 6 standard deviation (5#N cells#15). Knob diameter
and height were analyzed using mean 6 standard error of the mean (5#N cells#15). Scale bars: 1 mm.
doi:10.1371/journal.pone.0029039.g004
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The site of the chromosome breakpoint leading to the deletion
of the subtelomeric region was determined by PCR on the
telomere repeats and the genes suspected to be located there.
Based on the 3D7 genome sequence D10 has deleted around
120 kbp of the right arm of chromosome 9 [50] representing 25
genes, including clag9 (Fig. 6A), encoding a rhoptry protein [37].
CLAG9 was initially implicated in parasite adhesion to CD36 and
C32 cells [16] and recently in the adhesion to placental CSA [15].
To determine its potential role in the cytoadherence phenotype,
we inactivated the clag9 gene from P. falciparum 3D7. Targeted
disruption of clag9 was performed by replacing exons 2 through 6
with the hDHRF selectable marker (Fig. 6B). Gene knockout and
integration of the hDHFR cassette were confirmed by PCR
analysis (Fig. 6C) and Southern blotting using probes for exons 6
and hDHFR (Fig. 6D–F). CLAG9 was not detected in two
knockout clones (E5KO and F4KO), either by immunofluores-
cence (Fig. 7A and B) or western blotting (Fig. 7C). In contrast to
earlier reports implicating CLAG9 in cytoadhesion, our KO
parasites bound to both C32 cells (Fig. 7D) and CD36 (Fig. 7E) at
levels comparable to our control 3D7 parasites. These results show
that the clag9 gene product is not directly implicated in
cytoadhesion to CD36 and, therefore, in the non-cytoadherent
phenotype of the D10 strain.
Discussion
P. falciparum export several proteins beyond the parasite
membrane to the erythrocyte surface assuring the parasite’s
survival within the human host. A large number of these exported
molecules have been described that are essential for, or contribute
to, the trafficking of the major virulence factor PfEMP1 to the
erythrocyte surface. Here we describe a novel adhesion mutant
phenotype. In D10 PfEMP1 is trafficked to the surface of PRBC
but is unable to bind to host adhesion receptors. Even repeated
panning experiments on C32 cells or recombinant CD36 bound to
plastic dishes did not yield any increase in binding, showing that
no other var gene is able to restore the adhesion phenotype. Bulk-
cultured parasites typically contain minor populations expressing a
number of different var gene members (including CD36-binders).
Thus, our data indicate that in D10 non-functional PfEMP1
surface expression is implicated in the irreversible loss of
cytoadherence. We also have characterized another non-cytoad-
herent strain, T9-96 [46] with similar results (data not shown),
Figure 5. Expression and binding of D10
var1 CIDR1a minimal domain. A. Diagram of D10
var1. The different domains are shown, including the
location of the PfEMP1 CIDR1a minimal domain (M2) used for expression by COS-7 cells. The region spanning the intron between exons 1 and 2 of
D10
var1 was sequenced from cDNA. B. Beads bound to COS-7 cells expressing M2 on the surface. C. Quantification of binding on COS-7 cells. The
CIDR1a minimal domain of the D10
var1 PfEMP1 binds equally well to COS-7 cells as that of the Malayan Camp (MC
varCD36, positive control). In contrast,
there is no significant binding of the FCR3
var1CSA M2 domain. pDisplay control represents COS-7 cells transfected with pDisplay not containing the
insert.
doi:10.1371/journal.pone.0029039.g005
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missing from the right arm of chromosome 9, as compared to 3D7. The break point open reading frame (BPORF) is present but none of the 25 genes
between the BPORF and the telemores, including clag9 (red), were detected by PCR (data not shown). Each block corresponds to a single gene, clag9
and BPORF are larger for emphasis and the size of blocks does not illustrate gene size. The genes shown in yellow have been functionally identified.
The identity of the remaining genes has not yet been elucidated. B. Plasmid pCC1 exon 1+8 knockout leading to the disruption of the clag9 gene by
allelic exchange with insertion of the hDHFR selection marker. Primers (arrows) used for verification of KO and hDHFR integration, the restriction sites,
and Southern blot expected fragment sizes are shown. C. PCR analysis of 3D7 (lanes 1–4), the clag9 E5KO (lanes 5–8), and F4KO (lanes 9–12). Lanes 1,
5, and 9: 59UTR-F - exon 1-R; lanes 2, 6, and 10: 59UTR-F- hDHFR 59 out; lanes 3, 7, and 11: hDHFR 39 out – exon 8-RC39; lanes 4, 8, and 12: exon 2-F -
exon 6-R. D–F. Southern blot of clag9 knockout. Genomic DNA digested by EcoRI (lanes 1 and 4), SpeI (lanes 2 and 5) or EcoRI+SpeI (lanes 3 and 6)
separated on 0.8% agarose gel, transferred onto Hybond N+ and hybridized with different probes. D. Exon 1, present in both 3D7 and the clag9
E5KO. E. Hybridization of Exon 6 only with 3D7. F. Integration of the hDHFR selectable marker in the E5KO.
doi:10.1371/journal.pone.0029039.g006
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to chromosome 9 deletion.
Trypsin and chymotrypsin digestion experiments of surface
iodinated PRBC proteins suggest that PfEMP1 molecules
expressed at the surface of D10 display an unusual conformation
that protect them from the predicted protease cleavage. It may
also be the reason for the loss of the expected binding to CD36.
This idea is supported by the fact that recombinant CIDR1aof
D10
var1 binds efficiently to CD36 when expressed by another
eukaryotic cell. PfEMP1 may need ‘helper’ proteins acting as a
support or chaperones to assume the right shape to function as a
ligand. Alternatively, post-translational modifications and/or
processing of the protein during export may be needed to obtain
functional adhesion molecules. Further studies are required to
explore this hypothesis.
Are there candidate genes deleted on chromosome 9 of D10
that could contribute to the described adherence phenotype of
D10? Several studies have implicated clag9 in parasite adhesion to
CD36 and CSA [15,16]. We revisited this question by irreversibly
disrupting the clag9 gene by allelic replacement. The clag9
knockout in 3D7 resulted initially in low CD36 binding parasites,
which can be explained by the time taken to obtain cloned
knockout lines. However, after one panning step on CD36, these
clag9 mutants gained an adhesion capacity similar to the reference
parasite 3D7. Thus, our data demonstrate that 3D7, in contrast to
previous studies, does not depend on clag9 for the PfEMP1
adhesion process. At this stage, it is difficult to explain the different
set of clag9 knockout data. It cannot be ruled out that other gene
deletions known to occur during in vitro culture of 3D7, or
associated with the gene deletion [13], may have been picked up at
the cloning step after the knockout selection. This may mask the
observed phenotype of clag9 in the study reported by the Kemp
laboratory [16].
clag genes form a small gene family (5 members) and two
members (clag3.1 and 3.2) have recently been shown to
i n t e g r a t ei n t ot h ee r y t h r o c y t em e m b r a n ea n di n d u c ean e w
permeation pathway [51]. It is tempting to speculate that
CLAG9 may accomplish a similar function, a role that is not
essential during in vitro culture. Since CLAG9 apparently
integrates into the erythrocyte membrane, it may interact with
ap a r t i c u l a rm e m b e ro ft h ea d h e sion molecule family as has
recently been suggested for var2CSA [15]. Further receptor
binding studies of our clag9 knockout are needed to fully explore
this possibility.
Figure 7. Immunofluorescence and binding assays of clag9 E5KO. A. Labelling of CLAG9 in 3D7 and E5KO. Note there is labelling of E5KO
rhoptries with mAb7H8/50 but not with anti-CLAG9 specific sera due to gene disruption. Scale bars=5 mm. B. Trafficking of PfEMP1 and KAHRP by
E5KO; labelling was identical to 3D7. Scale bars=5 mm. C. Chemiluminescent western blot analysis of normal red blood cells (NRBC), E5KO and 3D7
parasite extracts reacted with anti-CLAG9 antibodies. D. Binding of clag9 E5KO on C32 melanoma cells. E. Binding assay of 3D7 and E5KO PRBC on
purified CD36 receptor. Error bars indicate the standard error of the mean from 4 experiments.
doi:10.1371/journal.pone.0029039.g007
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Maurer’s cleft-resident ring exported protein 1 (REX1). Its
deletion results in alteration of Maurer’s clefts architecture [49]
and a reduction of cytoadhesion to CD36 [13]. These data point
to REX1 as a plausible candidate gene for the observed adhesion
phenotype in D10. We assume that additional co-deleted genes
may act together with REX1 resulting in the complete loss of
adhesion. Although D10 is not known to possess any of the REX
proteins on chromosome 9, our data indicate that transit of
proteins in this parasite strain appears functional. Indeed, labelling
of PfEMP1 in D10 seems identical to that observed with the
cytoadherent FCR3
CD36. REX1 mutation resulted in the co-
deletion of a subtelometic region of 3D7 chromosome 2 including
KAHRP [13]. In our D10 parasites this is not observed since our
antibodies label KAHRP and AFM demonstrates the presence of
knobs. Dixon et al. [13] observe that REX1 deletion leads to
trypsin-resistant PfEMP1 and conclude that no PfEMP1 is
exposed on the PRBC. In the absence of surface iodination
experiments, however, it cannot be excluded that trypsin-resistant
PfEMP1 is expressed on the surface. Further characterization of
REX1 may unravel the function of this protein in the adhesion
process.
A large-scale loss-of-function study designed to characterize
candidate genes involved in interactions with PfEMP1 or with a
role in knob formation was performed by the Cowman laboratory
[11]. Fifty genes were functionally analysed and a number of
different adhesion phenotypes were linked to proteins required for
loading of PfEMP1 to Maurer’s clefts and function on the PRBC
surface. However, this study did not include genes deleted on
chromosome 9. In addition, the surface exposure of PfEMP1 was
only analysed by trypsin treatment, which releases a small trypsin-
resistant fragment (mainly composed of the ATS domain) between
70 and 90 kDa. Trypsin-resistant PfEMP1 was interpreted as
being not exposed on the surface of PRBC. Our data using surface
iodination experiments, however, show that parasites can expose
non-functional trypsin-resistant PfEMP1. Since PfEMP1 mole-
cules interact with KAHRP at the knob protrusions [9], we cannot
rule out that the slightly modified knobs structure observed in D10
(see Fig. 4), could contribute to the complete loss of adhesion in
D10. The role of the 25 genes deleted in D10 in this process will
require further analysis. To answer these questions, work is in
progress aiming to complement the deleted genes from chromo-
some 9 in D10 to establish which genes contribute to the
cytoadherence phenotype.
In conclusion, we have identified mutant parasites with non-
functional PfEMP1 surface expression. We also provide solid
experimental evidence that CLAG9 does not contribute in the
binding to CD36. In addition, our work illustrates that the factors
leading to functional surface expression of PfEMP1 are not well
elucidated and that the analysis of the genes deleted in D10 may
contribute to our understanding of parasite virulence.
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